Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus.

Borik L, Petzelbauer P, Quint T, Wöhrl S, Kinaciyan T, Heil PM.

J Eur Acad Dermatol Venereol. 2018 Sep 17. doi: 10.1111/jdv.15249. [Epub ahead of print] No abstract available.


Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.

Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC, Fain O, Huissoon A, Kinaciyan T, Farkas H, Lleonart R, Longhurst HJ, Rae W, Triggiani M, Aberer W, Cancian M, Zanichelli A, Smith WB, Baeza ML, Du-Thanh A, Gompels M, Gonzalez-Quevedo T, Greve J, Guilarte M, Katelaris C, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan W, Maurer M, Cicardi M.

N Engl J Med. 2018 Jul 26;379(4):352-362. doi: 10.1056/NEJMoa1716995.


Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias.

Garner-Spitzer E, Seidl-Friedrich C, Zwazl I, Hofer M, Kinaciyan T, Jarisch R, Stiasny K, Zlabinger GJ, Kundi M, Wiedermann U.

Vaccine. 2018 May 11;36(20):2816-2824. doi: 10.1016/j.vaccine.2018.03.076. Epub 2018 Apr 16.


Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.

Kinaciyan T, Nagl B, Faustmann S, Frommlet F, Kopp S, Wolkersdorfer M, Wöhrl S, Bastl K, Huber H, Berger U, Bohle B.

J Allergy Clin Immunol. 2018 Mar;141(3):1002-1008. doi: 10.1016/j.jaci.2017.07.036. Epub 2017 Sep 1.


Prime and boost aerosol exposure via fog machine or shisha smoke followed by cinnamon hypersensitivity and anaphylaxis to spiced food.

Jensen-Jarolim E, Roth-Walter F, Leitner E, Buchleitner S, Vogelsang H, Kinaciyan T.

World Allergy Organ J. 2016 Jan 27;9:4. doi: 10.1186/s40413-016-0091-6. eCollection 2016.


Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.

Kinaciyan T, Nagl B, Faustmann S, Kopp S, Wolkersdorfer M, Bohle B.

Allergy. 2016 Feb;71(2):272-4. doi: 10.1111/all.12781. Epub 2015 Nov 6.


Caution: Reptile pets shuttle grasshopper allergy and asthma into homes.

Jensen-Jarolim E, Pali-Schöll I, Jensen SA, Robibaro B, Kinaciyan T.

World Allergy Organ J. 2015 Aug 17;8(1):24. doi: 10.1186/s40413-015-0072-1. eCollection 2015.


Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer.

Roth-Walter F, Moskovskich A, Gomez-Casado C, Diaz-Perales A, Oida K, Singer J, Kinaciyan T, Fuchs HC, Jensen-Jarolim E.

PLoS One. 2014 Oct 1;9(10):e108402. doi: 10.1371/journal.pone.0108402. eCollection 2014.


Impact of sulfur and vitamin C on the allergenicity of Mal d 2 from apple (Malus domestica).

Marzban G, Kinaciyan T, Maghuly F, Brunner R, Gruber C, Hahn R, Jensen-Jarolim E, Laimer M.

J Agric Food Chem. 2014 Jul 30;62(30):7622-30. doi: 10.1021/jf5020878. Epub 2014 Jul 16.


Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy.

Kollmann D, Geroldinger-Simic M, Kinaciyan T, Huber H, Ebner C, Lidholm J, Bohle B.

J Allergy Clin Immunol. 2013 Oct;132(4):1008-10. doi: 10.1016/j.jaci.2013.05.030. Epub 2013 Jun 28. No abstract available.


Glutathione exposes sequential IgE-epitopes in ovomucoid relevant in persistent egg allergy.

Roth-Walter F, Starkl P, Zuberbier T, Hummel K, Nöbauer K, Razzazi-Fazeli E, Brunner R, Pali-Schöll I, Kinkel J, Felix F, Jensen-Jarolim E, Kinaciyan T.

Mol Nutr Food Res. 2013 Mar;57(3):536-44. doi: 10.1002/mnfr.201200612. Epub 2013 Jan 24.


Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.

Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B.

J Allergy Clin Immunol. 2013 Jan;131(1):94-102. doi: 10.1016/j.jaci.2012.06.039. Epub 2012 Aug 24.


Malignancy and specific allergen immunotherapy: the results of a case series.

Wöhrl S, Kinaciyan T, Jalili A, Stingl G, Moritz KB.

Int Arch Allergy Immunol. 2011;156(3):313-9. doi: 10.1159/000323519. Epub 2011 Jun 29.


Severe scombroid fish poisoning: an underrecognized dermatologic emergency.

Jantschitsch C, Kinaciyan T, Manafi M, Safer M, Tanew A.

J Am Acad Dermatol. 2011 Jul;65(1):246-7. doi: 10.1016/j.jaad.2009.12.058. Review. No abstract available.


Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model.

Riemer AB, Gruber S, Pali-Schöll I, Kinaciyan T, Untersmayr E, Jensen-Jarolim E.

Clin Exp Allergy. 2010 Mar;40(3):486-93. doi: 10.1111/j.1365-2222.2009.03363.x. Epub 2009 Oct 7.


Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.

Jalili A, Kinaciyan T, Barisani T, Peck-Radosavljevic M, Stingl G, Geusau A, Wöhrl S.

Iran J Immunol. 2009 Mar;6(1):55-8. doi: IJIv6i1A6. No abstract available.


Photoallergic contact dermatitis to Heracleum giganteum.

Karimian-Teherani D, Kinaciyan T, Tanew A.

Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):99-101. doi: 10.1111/j.1600-0781.2008.00346.x.


The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.

van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, Villalba M, Durham SR, Becker WM, Aalbers M, André C, Barber D, Cistero Bahima A, Custovic A, Didierlaurent A, Dolman C, Dorpema JW, Di Felice G, Eberhardt F, Fernandez Caldas E, Fernandez Rivas M, Fiebig H, Focke M, Fötisch K, Gadermaier G, Das RG, Gonzalez Mancebo E, Himly M, Kinaciyan T, Knulst AC, Kroon AM, Lepp U, Marco FM, Mari A, Moingeon P, Monsalve R, Neubauer A, Notten S, Ooievaar-de Heer P, Pauli G, Pini C, Purohit A, Quiralte J, Rak S, Raulf-Heimsoth M, San Miguel Moncin MM, Simpson B, Tsay A, Vailes L, Wallner M, Weber B.

Allergy. 2008 Mar;63(3):310-26. doi: 10.1111/j.1398-9995.2007.01612.x. Review.


Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.

Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C.

J Allergy Clin Immunol. 2007 Sep;120(3):707-13. Epub 2007 Aug 6.


Premedication with montelukast reduces local reactions of allergen immunotherapy.

Wöhrl S, Gamper S, Hemmer W, Heinze G, Stingl G, Kinaciyan T.

Int Arch Allergy Immunol. 2007;144(2):137-42. Epub 2007 May 25.


Supplemental Content

Loading ...
Support Center